Johnson & Johnson (JNJ)
$160.30 0.35 (0.22%)
19:59 EST JNJ Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 429.95B
PE Ratio 348.48
Volume (Avg. Vol.) 7.63M
Day's Range 159.11 - 161.41
52-Week Range 109.16 - 161.95
Dividend & Yield 3.48 (2.17%)
JNJ Stock Predictions, Articles, and Johnson & Johnson News
- From InvestorPlace
- From the Web
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.
With growth names still flying high, value stocks to buy doesn’t exactly inspire excitement. Nevertheless, it could be the most prudent choice ahead of an uncertain 2021.
By Alex Sirois
Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.
The Covid-19 vaccine rally isn’t just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.
As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.
It’s time to start considering some of the best stocks to buy for 2021. However, these 12 selections come with a bit of a twist.
Just because a stock pays a dividend, does not mean that yield is safe. Let's look at the best dividend stocks to own going forward.
As you make portfolio adjustments heading into 2021, these seven undervalued stocks could be just what you're looking for.
With a pandemic and politics colliding, it’s a confusing time to be an investor. But you can improve the odds by banking on the best stock in each sector.
With the markets reaching new highs, it might be time to get defensive, and that means considering these seven blue-chip stocks.
These dividend stocks continue to outperform thier competition in yielding higher and consistent returns despite the impact of the pandemic
These healthcare stocks can deliver steady growth in the coming decade as demographics suggest tailwinds for the industry.
As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.
Johnson & Johnson is trading at its historic fair valuation. In today's frothy market, that makes JNJ stock quite a good blue chip holding.
Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.
From Talk Markets
From The Motley Fool
From Yahoo Finance
South Africa, which has yet to receive its first coronavirus vaccine, has been promised 9 million doses by Johnson & Johnson, the Business Day newspaper reported on Monday, citing a health ministry spokeswoman. The government of Africa's most advanced economy is scrambling to secure enough COVID-19 vaccines, after health workers and scientists publicly criticised it for not moving fast enough to inoculate its people. The country has recorded more than 1.3 million infections and more than 37,000 deaths related to the virus, the most in Africa.
Navellier RatingsPowered by Portfolio Grader